Viasys gains FDA nod for SLEEPSCREEN device:
This article was originally published in Clinica
The US FDA has given Viasys Healthcare the green light to market its SLEEPSCREEN system for diagnosing obstructive sleep apnoea (OSA) and for monitoring various sleep therapies. The clearance includes use of the product in the home. OSA affects around 12 million individuals in the US alone, with the majority undiagnosed, says the Conshohocken, Pennsylvania firm.